ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GDR Genedrive Plc

1.70
0.05 (3.03%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.03% 1.70 1.65 1.75 1.75 1.65 1.65 19,246,974 16:04:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.79 9.23M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.65p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £9.23 million. Genedrive has a price to earnings ratio (PE ratio) of -1.79.

Genedrive Share Discussion Threads

Showing 5901 to 5920 of 27175 messages
Chat Pages: Latest  247  246  245  244  243  242  241  240  239  238  237  236  Older
DateSubjectAuthorDiscuss
03/2/2021
13:57
More buying than selling !! Price being held in a holding pattern
maverick081267
03/2/2021
13:42
Yes i agree. Also AIHL test is also gonna be winner
yasyas1
03/2/2021
13:36
Yas, as we now have avenues to a much wider market thanks to BC, I can forsee the share price going back to previous highs. Obviously, this is dependent upon Sales growth seriously ramping up.

Some of this Sales may well fall under the radar with tests that are going on but no worthy of mentioning under an RNS, unless a contract of significant amount is attained.

k1ngkonggb
03/2/2021
13:33
Got in here at 1.20 and hoping we will well surpass that over next few months with plenty in pipeline! I dont think £2 or even £3 is unreasonable in next couple of months
yasyas1
03/2/2021
12:45
agreed, just filter it !!!
stoxx67
03/2/2021
12:42
Bunz please can you give it a rest. I am a holder in this stock and have only signed in here due to your incessant ramping. You are giving the impression that us holders need more buyers to get the price up, we dont, the company is potentially going to start selling their tests and that will be all the shareprice boost we need.

You posting the same nonsense hour after hour is probably doing more harm than good. If I stumbled upon a message board with the same people going on and on then I would assume pump and dump. Can you PLEASE give it a rest.

aimsuperfan
03/2/2021
12:41
You can't blame the profit takes it's gone up 100%!from the lows. Peeps have doubled their money.What don't realise is this is going to Quadruple from the lows!Wait and see... let's get the tree shakes out of the way to weed out the weak twitchy holders
losses
03/2/2021
12:29
NT to buy again ,even with so much selling this morning
bunz3
03/2/2021
12:23
part of last weeks rns

Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testingst


The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

bunz3
03/2/2021
12:16
will Tomorrow morning see more of a move up again
bunz3 - 02 Feb 2021 - 16:07:36 - 3920 of 4014 Genedrive. A Game Changer for Global Covid 19 Testing Market? - GDR
with how low the supply of available shares lookes to be Today with how much nt being quoted

how much this moving up with volume ,next week if more people who have read last weeks rns wanting in before Mid February ,how much is this likely to move up
find this part of last weeks rns interesting




The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

bunz3
03/2/2021
12:12
Pump and dump fools
oilisgold
03/2/2021
12:11
Get a freakung better broker.
oilisgold
03/2/2021
12:10
A market maker is always inclined to help a big institutional buyer get their price what they want at the expense of the retail PI. The next move will be parabolic pas 100p and we won't look back.
richardp19
03/2/2021
12:09
The mms have restricted buying now sell go 90.75 they make it nt to buy. What is going on but looks positive whatever games they are playing. Can anyone get a buy quote I cannot on HL
richardp19
03/2/2021
12:08
Peel @ 94 Fcap @95.. tick up coming
bunz3
03/2/2021
12:06
You're right Rich lots of delayed trades being brought out.

Oh what tangled web we weave!

hazl
03/2/2021
11:59
sell price moving up more ,
now up to 91p to sell
not so easy to buy

bunz3
03/2/2021
11:50
Sell only can't buyMms putting through the delayed sells to scare a few into selling
richardp19
03/2/2021
11:46
Tr1 could land any minute
richardp19
03/2/2021
11:40
30,000 buy trade ,or order filled ,assuming that part of reason why N T to buy shares
bunz3
Chat Pages: Latest  247  246  245  244  243  242  241  240  239  238  237  236  Older

Your Recent History

Delayed Upgrade Clock